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Abstract
Background: The etiology of traumatic ulcerative granulomas with stromal eosinophilia (TUGSE) is not clear, traumatic
irritation having advocated as the most likely cause. TUGSEs are typically self-limiting slow-healing lesions of the oral
mucosa with unclear pathogenesis, commonly manifesting as a rapidly developing, long-lasting ulcer.
Case presentation: Here we report a controversial case of a self-healing lesion of the tongue in a 57 year-old woman.
A clonal T-cell proliferation and CD30 negative immunohistochemical (IHC) profile could be documented.
Discussion and conclusion: In view of the very peculiar clinical and histological features, a retrospective diagnosis of a
TUGSE with scarce eosinophilic infiltrate (possibly in regression), displaying CD30- T-clonal proliferation was eventually
rendered.
The patient did not report signs of recurrence after a 3-year follow-up period.
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Background
Self-healing CD30- T-clonal proliferations of the oral cav-
ity are exceedingly rare, existing only sporadic reports [1].
Mucosal lesions having such a peculiar immunohisto-
chemical (IHC) pattern could underlay the heterogeneous
histologic aspect of traumatic ulcerative granulomas with
stromal eosinophilia (TUGSE). TUGSEs are typically self-
limiting slow-healing lesions of the oral mucosa with un-
clear pathogenesis, commonly manifesting as a rapidly de-
veloping ulcer. Lesions usually persist for weeks or
months with elevated or rolled borders [2].
The etiology of TUGSE is not clear, traumatic irrita-
tion having advocated as the most likely cause [3]). Clin-
ically, they may mimic squamous cell carcinoma (SCC),
warranting a biopsy or excision. TUGSEs are most often
found on the tongue but they can occur in other areas,
including gingiva, buccal and vestibular mucosa. Rapid
healing after a biopsy is typical.
Different studies have demonstrated expression of CD30
and T cell–lineage antigens, suggesting that atypical mono-
nuclear cells are of T-cell origin. Moreover, molecular evi-
dence of T-cell clonality within TUGSE was described,
raising the possibility that a subgroup of these lesions could
be classified as low-grade CD30+ T-cell lymphoproliferative
disorders [4]. T-cell clonality has been described in various
benign and reactive conditions, and its presence does not
necessarily indicate a T-cell malignancy. Additionally, some
authors have hypothesized that TUGSE may be the oral
counterpart of primary cutaneous CD30+ lymphoprolifera-
tive disorder [5].
Here we report a controversial case of a self-healing le-
sion of the tongue with clonal T-cell proliferation and
CD30- IHC profile.
Case presentation
A 57 year-old woman was referred to the Unit of Oral
Medicine and Laser Surgery of the University of Parma,
Italy, because of a 15 days standing, painful lesion on the
right border of the tongue. Clinical investigation re-
vealed the presence of a round, nodular, ulcerated,
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slightly exophytic lesion of the right posterior border of
the tongue, in proximity of the ventral portion (Fig. 1).
Lesion measured approximately 3 cm in diameter. Ac-
cording to the patient, no mechanical or thermal trauma
had occurred.
Swelling of the affected part of the tongue was
appreciable on palpation; no mobility impairment or
presumptive infiltration in the deeper muscular
layers were evident. Gauze swiping did not remove
the fibrin-like material from the surface of the
lesion.
Neck palpation did not allow the disclosure of enlarged
cervical, supraclavicular, occipital and pre-auricular nodes.
Medical history was negative. Patient was non-smoker
and she referred no alcohol consumption.
Differential diagnosis included: SCC, bacterial infec-
tions (e.g.: tuberculosis), lymphoproliferative disorder,
chronic eosinophilic ulceration and possible trauma or
chronic mutilation of which patient was not aware.
Two incisional biopsies were taken in the most suspi-
cious parts (Fig. 2).
Further work-up included complete blood tests, chest
x-rays, neck nodes and spleen ultrasonography (US), and
magnetic resonance imaging of the head and neck
region.
Histological features included a polymorphic lympho-
cytic infiltrate with slight eosinophilia (Fig. 3). Epithelium
presented ulceration with signs of pseudoepitheliomatous
hyperplasia.
IHC analysis showed a lymphoid infiltrate with the fol-
lowing characterization: CD3+, CD2+, CD4+, CD8-,
CD5+, CD7-, CD56-, Perforin -, CD30−/Ber-H2-, CD20-,
CD1A-.(Figs. 4 and 5) Epstein-Barr Virus (EBV) investiga-
tion (Fluorescein-Conjugated Epstein-Barr Virus staining,
EBER) was negative. Proliferation index Ki67 was 50%.
Cytokeratin pool investigation was negative.
Multiplexed polymerase chain reaction (PCR) revealed
the presence of a monoclonal pattern and TCRγ (T cell
receptor gamma) gene rearrangement (region Vg1–8/
Vg10 - Jg 1.1/2.1 - Jg 1.3/2.3) (Fig. 6).
Imaging and laboratory work-up was negative. In con-
trast with the seriousness of the clinical appearance,
complete remission with mucosal healing spontaneously
occurred in 15 days (Fig. 7).
In view of the very peculiar clinical and histological
features, a retrospective diagnosis of a TUGSE with
scarce eosinophilic infiltrate (possibly in regression), dis-
playing CD30- T-clonal proliferation was eventually
rendered.
The patient did not report signs of recurrence after a
3-year follow-up period (Fig. 8).
Discussion and conclusion
Benign and malignant lymphoproliferative disorders may
mimic either common oral conditions, including muco-
sal burns (chemical or thermal), traumatic ulcerations,
Fig. 1 Lesion clinical appearance. Round, nodular, ulcerated, slightly
exophytic lesion of the right posterior border of the tongue, in proximity
of tongue ventral portion
Fig. 2 Multiple incisional biopsies surgical procedure
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SCC and rare lesions such as EBV+ mucosal ulcer and
TUGSE. Such lesions therefore need an extremely accur-
ate differential diagnosis.
Eosinophilic ulcer is a rare benign, reactive and
self-limiting entity, first described clinically in infants
by Riga in 1881 and histologically by Fede in 1890
(Riga-Fede disease) [6]. Described in adult by Popoff
in 1956, it was identified as a distinct entity by Sha-
piro and Juhlin in 1970 [7]. The lesion has been
indicated through different names, including traumatic
eosinophilic granuloma of tongue, traumatic granu-
loma, atypical histiocytic granuloma and TUGSE [3].
A bimodal age distribution, with the first peak occur-
ring at early childhood and the second during the 6th
and 7th decade of life, has been reported [8]. No sig-
nificant gender predilection has been highlighted, al-
though some authors have evidenced a slightly higher
female prevalence [9, 10].
Fig. 3 Histological examination, hematoxylin and eosin A-4x and B-10x. A polymorphic lymphocytic infiltrate with slight eosinophilia is
appreciable. Epithelium presented ulceration with signs of pseudoepitheliomatous hyperplasia
Fig. 4 IHC analysis showed a lymphoid infiltrate with the following characterization: CD3+, CD2+, CD4+, CD8-, CD5+, CD7-
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The etiology of TUGSE is mostly unknown, although
mechanical trauma has been considered as a typical trig-
ger [3]. Some authors suggested that trauma could be a
contributing factor in the development of ulcers, by
leading to microbial infections followed by intense in-
flammatory response [11]. Others authors stated that
cell-mediated immunity [12], CD30 lymphoproliferative
disorders [4, 5, 13], mast cell- eosinophil interaction [14]
and stress [15] may play a primary role in the pathogen-
esis of the lesion. Delayed healing of TUGSE lesions has
been reported to be associated with the lack of secretion
of transforming growth factor-α (TGF-α) and TGF-β by
eosinophils infiltrating the lesions.
TUGSE commonly involves the tongue; other affected
sites are the buccal and, labial mucosa the floor of the
mouth the palate and vestibule. Lymphadenopathy can
occur but it is extremely rare [12]. Clinically, the lesion
appears as a singular entity. A case of multiple lesions
has been reported in a young man affected by Riley-Day
syndrome [7].
The lesion usually presents with raised, indurated bor-
ders and a yellow fibrinous floor. Because of its clinical
appearance as well as the frequent long-standing dur-
ation, a suspicion of malignancy is usually included in
the differential diagnosis.
Form the histologic point of view, under an ulcerated
mucosa, a poorly formed granulation tissue showing an
increased number of capillaries with prominent endothe-
lial cells is usually observed. A dense submucosal poly-
morphous inflammatory infiltrate occasionally involving
Fig. 5 IHC analysis showed a lymphoid infiltrate with CD30−/Ber-H2- characterization (20x)
Fig. 6 Molecular analysis - Monoclonality of TCRγ analysis: rearrangement was positive, showing monoclonal proliferation
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the overlying epithelium is frequently present. The infil-
trate have a tendency to extend to the deeper soft tis-
sues, (e.g. muscle fibers and salivary glands). The
inflammatory infiltrate is composed of small round lym-
phocytes, abundant polymorphonuclear eosinophils and
other inflammatory cells (neutrophils, plasma cells and
histiocytes) [5, 10, 13, 14].
Large mononuclear atypic cells, intermingled in the inflam-
matory infiltrate are also frequently observed, occasionally
(24% cases) with T-cell receptor gene rearrangement [1].
Many treatments are reported in literature, including
wait-and-see, antibiotics, topical, intra-lesion and/or sys-
temic corticosteroids, curettage, cryosurgery and surgical
excision/incision [7]. Furthermore, it has been suggested
to remove sources of local irritation (e.g. sharp teeth).
Spontaneous healing frequently occurs within 30 days,
even if cases of 8-month standing lesions have been re-
ported [16].
Differential diagnosis of TUGSE may include mucosal
burns (chemical or thermal), traumatic ulcer, malignancies
(e.g. SCC or B-cell lymphoma), major aphthae (Sutton’s
disease), Bechet’s syndrome, oral tuberculosis, primary
syphilis or the recently documented Epstein-Barr virus
positive muco-cutaneous ulcer (EBV MCU). EBV MCU
has been described in the oral cavity, gastrointestinal tract,
and skin. Such lesion, represent a unique, indolent form of
EBV-driven B-cell lymphoproliferative disorder that pre-
sents as isolated, well-delineated ulcers. Documented
cases have occurred in patients on immunosuppressive
medication, in the elderly with age related immune-senes-
cence and in immunodeficiency caused by HIV infection.
In the present case, the site (border of the tongue), the
ulcerative/nodular clinical pattern, as well as the absence
of causing factors, as reported in the anamnesis, were
highly suggestive of a malignant lesion. Such features
justified the immediate taking of multiple biopsies.
Apart from the extremely rare histopathologic and
IHC pattern, the peculiarity of the case reported here
lays on the surprising and unexpected benign clinical
behavior, in contrast to a diagnosis, at least in the
early phases, suggesting a T-cell lymphoproliferative
disease.
In cases of diagnostic doubts it is always strongly rec-
ommended to carefully search for other features typical
of malignant lymphoma. Features like abundant atypical
cells infiltrate, significant mitotic activity, and infiltration
into blood vessel walls should be investigated. In some
cases, however, the diagnosis may be difficult to reach
with confidence on the basis of histologic and IHC find-
ings alone. For example, low-grade lymphoma is usually
recognized only retrospectively, if lesions recur several
times, spread to other areas, or they develop more pro-
nounced microscopic malignant features [2].
CD30 is a transmembrane protein of the tumor necro-
sis factor (TNF) family; is a lymphocyte activation anti-
gen important in diagnosis of classic Hodgkin’s
lymphoma, anaplastic large cell lymphoma, embryonal
carcinoma and primary cutaneous CD30+ T-cell lym-
phoproliferative disorders.
CD30+ cells scattered or clustered infiltrates were
found in 5 out of 12 (42%), 11 out of 19 (58%), and 26
out of 37 TUGSE lesions (70%), as reported by Hirsh-
berg et al., Fonseca et al. and Salisbury et al., respectively
[1, 2, 10]. These CD30+ cells in TUGSE lesions include
large mononuclear cells and small reactive T cells [17].
CD30- T-clonal oral lesions are very uncommon and,
to the best of our knowledge, only two cases have been
documented in details [1]. In both cases no recurrences
were reported in a follow-up of 2 and 26months. Nega-
tivity to CD30 is in contrast with the usual pattern of
primary mucosal lymphoproliferative disorders which
are CD30 + .
Fig. 7 Complete self-healing after 15 days recall
Fig. 8 Tongue control after 3 years. No sign or symptoms of recurrence
were registered during follow-up
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Immunohistochemistry for CD30 protein and PCR ana-
lysis for the TCR chain gene has shown that some atypical
TUGSE display CD30 cells and they have a monoclonal
rearrangement of the TCRγ chain gene [1, 2]. However,
negative expression of anaplastic lymphoma kinase pro-
tein, a marker associated with large cell CD30+ lymph-
oma, supported the reactive nature of the lesions.
In the present case, TCRγ rearrangement was positive,
showing monoclonal proliferation. However, no further
evidences suggested a malignant behavior. Clonal prolif-
eration was also described in CD30- lesions, with no in-
fluence on disease progression [1].
In view of the very heterogeneous histological pattern
and clinical behavior of TUGSE and TUGSE-like lesions,
careful management of patients is recommended. In
cases of doubts, further work-up and close follow-up ex-
aminations should be performed in order to confirm or
exclude the presence of malignant disorders such as
lymphomas [18].
TUGSE should be regarded as a benign, reactive lesion
rather than a T-cell lymphoproliferative disorder. Simi-
larly to the case described here, TUGSEs with clonal
TCR gene rearrangements reported in the literature had
a benign clinical course. Our patient did not present fur-
ther oral, systemic or skin lesions during a 3-year fol-
low-up.
Detection of a dominant clone of a T-cell population
as a single feature in a lymphoproliferative process is in-
sufficient to diagnose a T-cell lymphoma. Because spon-
taneous regression of T-cell lymphoma is a recognized
phenomenon, in the presence of monoclonality, a
lymphoma work-up should always be undertaken.
In conclusion, without clinical, morphologic, or other
supporting evidence, T-cell lymphoproliferative disorder
diagnosis is not warranted. Overtreatment should be
avoided.
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